WallStreetZenWallStreetZen

AnalystsTony Butler
Tony Butler's Stock Forecasts

Analyst Ranking
Bottom 4%
#4352 out of 4529 analysts
Average Return
-4.75%
Win Rate
40%45 out of 112
Risk vs Reward
Poor
Good

Tony Butler's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Compugen LtdCGEN
+177.42%$0.93$2.58
2023-05-24 -
2024-03-28
Strong Buy
Compugen LtdCGEN
+150.49%$1.03$2.58
2023-08-07 -
2024-03-28
Strong Buy
Merus NvMRUS
+149.13%$19.46$48.48
2023-03-01 -
2024-02-29
Strong Buy
Compugen LtdCGEN
+143.40%$1.06$2.58
2023-05-26 -
2024-03-28
Strong Buy
Fate Therapeutics IncFATE
+115.88%$3.40$7.34
2023-08-09 -
2024-03-28
Strong Buy

Tony Butler Analyst Color

Get additional color on Tony Butler's coverage of popular stocks

Tony Butler's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Century Therapeutics IncIPSC
5Strong Buy$16.00+282.78%Reiterates
8 months ago
Adaptimmune Therapeutics PLCADAP
8Strong Buy$10.00+532.91%Reiterates
8 months ago
Fate Therapeutics IncFATE
4Strong Buy$10.00+36.24%Reiterates
8 months ago
Crispr Therapeutics AgCRSP
7Strong Buy$75.00+10.04%Reiterates
8 months ago
Merus NvMRUS
7Strong Buy$35.00-22.27%Reiterates
8 months ago
Gt Biopharma IncGTBP
5Hold$60.00+1,254.40%Reiterates
8 months ago
Compugen LtdCGEN
6Strong Buy$13.00+403.88%Reiterates
8 months ago
Bicycle Therapeutics PLCBCYC
5Strong Buy$50.00+100.80%Reiterates
8 months ago
Allogene Therapeutics IncALLO
7Strong Buy$15.00+235.57%Reiterates
8 months ago
G1 Therapeutics IncGTHX
4Strong Buy$19.00+339.81%Reiterates
8 months ago
Bioatla IncBCAB
6Strong Buy$25.00+626.74%Reiterates
8 months ago
Biomea Fusion IncBMEA
3Strong Buy$43.00+187.63%Reiterates
8 months ago
Pyxis Oncology IncPYXS
1Strong Buy$15.00+252.11%Initiates Coverage On
8 months ago
Viracta Therapeutics IncVIRX
1Strong Buy$10.00+880.39%Initiates Coverage On
8 months ago
Cel Sci CorpCVM
3Strong Buy$10.00+423.56%Reiterates
9 months ago
Calcimedica IncCALC
2Strong Buy$17.00+308.65%Reiterates
9 months ago
Agenus IncAGEN
4Strong Buy$8.30+1,331.03%Reiterates
9 months ago
Replimune Group IncREPL
4Strong Buy$60.00+634.39%Reiterates
10 months ago
In8bio IncINAB
4Strong Buy$8.00+577.97%Reiterates
10 months ago
Aravive IncARAV
5Strong Buy$10.00+24,900.00%Reiterates
10 months ago
Volitionrx LtdVNRX
1Strong Buy$6.00+692.60%Assumes
10 months ago
Hcw Biologics IncHCWB
1Strong Buy$9.00+414.29%Assumes
10 months ago
Rain Oncology IncRAIN
6Hold$2.00+65.29%Maintains
10 months ago
Apexigen IncAPGN
4Hold$0.64+66.23%Reiterates
10 months ago
Ocean Biomedical IncOCEA
1Strong Buy$17.00+349.14%Assumes
10 months ago
Atreca IncBCEL
2Strong Buy$10.00+6,566.67%Reiterates
a year ago
Tcr2 Therapeutics IncTCRR
3Hold$2.00N/AReiterates
a year ago
Atara Biotherapeutics IncATRA
1Strong Buy$25.00N/AInitiates Coverage On
a year ago
Genenta Science SpaGNTA
1Strong Buy$15.00N/AInitiates Coverage On
a year ago
Ayala Pharmaceuticals IncAYLA
2Strong Sell$0.55N/ADowngrades
a year ago
Humanigen IncHGENQ
2Hold$2.00N/ADowngrades
2 years ago
Marker Therapeutics IncMRKR
2Hold$10.00N/ADowngrades
2 years ago
Compass Therapeutics IncCMPX
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Translate Bio IncTBIO1
3Hold$38.00N/AMaintains
3 years ago
Intellia Therapeutics IncNTLA
2Strong Buy$110.00N/AMaintains
3 years ago
Panbela Therapeutics IncPBLA
1Strong Buy$240,000.00N/AInitiates Coverage On
3 years ago
Nextcure IncNXTC
1Strong Buy$80.00N/AInitiates Coverage On
4 years ago
Arqule IncARQL
1HoldN/AN/ADowngrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.